COHANCE - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.7
| Stock Code | COHANCE | Market Cap | 18,488 Cr. | Current Price | 483 ₹ | High / Low | 1,180 ₹ |
| Stock P/E | 54.7 | Book Value | 115 ₹ | Dividend Yield | 0.00 % | ROCE | 16.0 % |
| ROE | 12.5 % | Face Value | 1.00 ₹ | DMA 50 | 367 ₹ | DMA 200 | 576 ₹ |
| Chg in FII Hold | -0.42 % | Chg in DII Hold | 0.22 % | PAT Qtr | 50.8 Cr. | PAT Prev Qtr | 94.3 Cr. |
| RSI | 73.8 | MACD | 37.0 | Volume | 1,32,56,155 | Avg Vol 1Wk | 1,99,12,580 |
| Low price | 267 ₹ | High price | 1,180 ₹ | PEG Ratio | -2.65 | Debt to equity | 0.05 |
| 52w Index | 23.7 % | Qtr Profit Var | -67.0 % | EPS | 9.90 ₹ | Industry PE | 30.1 |
📊 Financials: COHANCE shows moderate fundamentals with ROE at 12.5% and ROCE at 16.0%, reflecting average efficiency. EPS of ₹9.90 provides earnings visibility, but quarterly PAT declined sharply from ₹94.3 Cr. to ₹50.8 Cr. (-67%), highlighting weak profitability momentum. Debt-to-equity at 0.05 indicates very low leverage, supporting financial stability.
💹 Valuation: The stock trades at a P/E of 54.7, well above the industry average of 30.1, suggesting overvaluation. Book value of ₹115 results in a P/B of ~4.2, expensive relative to peers. PEG ratio of -2.65 highlights poor valuation alignment with growth prospects. Intrinsic value appears lower than current price, limiting margin of safety.
🏢 Business Model: COHANCE operates in specialty chemicals, benefiting from global demand and industrial applications. Its competitive advantage lies in low debt and moderate profitability metrics. However, declining profits and reduced foreign institutional confidence (FII -0.42%) weaken sentiment, though DII holdings increased slightly (+0.22%).
🎯 Entry Zone: Safer entry between ₹450–470, near DMA support levels. Long-term investors may hold for 2–3 years, with exit considerations if ROE falls below 10% or profitability continues to decline.
Positive
- Low debt-to-equity ratio (0.05) ensures financial stability.
- Moderate ROCE (16.0%) and ROE (12.5%).
- DII holdings increased (+0.22%), showing some domestic confidence.
Limitation
- High P/E (54.7) vs industry average (30.1).
- Negative PEG ratio (-2.65) highlights poor valuation alignment.
- Quarterly PAT declined sharply (-67%).
- No dividend yield (0.00%).
- RSI at 73.8 suggests overbought levels.
Company Negative News
- Sharp decline in quarterly profits and reduced FII interest highlight weak sentiment.
Company Positive News
- Low debt levels strengthen financial stability.
- Moderate profitability metrics provide some resilience despite valuation concerns.
Industry
- Specialty chemicals sector remains resilient with global demand.
- Industry PE at 30.1 suggests COHANCE trades at a steep premium relative to peers.
Conclusion
⚠️ COHANCE is a moderately profitable company but currently overvalued with weak institutional support. Entry near ₹450–470 offers safety for speculative investors, while holding for 2–3 years could yield moderate returns if profitability improves and valuations normalize.